Bank Of New York Mellon Corp Veracyte, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $3.91 Million - $7.65 Million	255,453 New	255,453 $6.06 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $371,275 - $624,764	22,393 Added 9.63%	254,834 $4.23 Million
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $1.61 Million - $3.07 Million	-104,002 Reduced 30.91%	232,441 $4.63 Million
Q1 2022 May 11, 2022	SELL	$21.94 - $42.51 $264,508 - $512,500	-12,056 Reduced 3.46%	336,443 $9.28 Million
Q4 2021 Feb 11, 2022	SELL	$36.09 - $53.79 $110,254 - $164,328	-3,055 Reduced 0.87%	348,499 $14.4 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $62,085 - $92,326	1,743 Added 0.5%	351,554 $16.3 Million
Q2 2021 Aug 11, 2021	SELL	$32.94 - $56.62 $16.1 Million - $27.7 Million	-490,088 Reduced 58.35%	349,811 $14 Million
Q1 2021 May 13, 2021	BUY	$44.47 - $81.38 $3.19 Million - $5.83 Million	71,623 Added 9.32%	839,899 $45.1 Million
Q4 2020 Feb 09, 2021	BUY	$32.49 - $61.88 $696,065 - $1.33 Million	21,424 Added 2.87%	768,276 $37.6 Million
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $1.63 Million - $2.18 Million	61,012 Added 8.9%	746,852 $24.3 Million
Q2 2020 Aug 12, 2020	BUY	$19.49 - $28.11 $619,626 - $893,673	31,792 Added 4.86%	685,840 $17.8 Million
Q1 2020 May 06, 2020	BUY	$16.13 - $30.17 $253,821 - $474,755	15,736 Added 2.47%	654,048 $15.9 Million
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $358,413 - $517,267	-17,248 Reduced 2.63%	638,312 $17.8 Million
Q3 2019 Nov 07, 2019	BUY	$23.87 - $30.93 $8.79 Million - $11.4 Million	368,403 Added 128.29%	655,560 $15.7 Million
Q2 2019 Aug 12, 2019	BUY	$22.1 - $28.56 $3 Million - $3.88 Million	135,902 Added 89.85%	287,157 $8.19 Million
Q1 2019 May 14, 2019	SELL	$12.0 - $25.76 $141,360 - $303,452	-11,780 Reduced 7.23%	151,255 $3.79 Million
Q4 2018 Feb 11, 2019	BUY	$9.15 - $14.85 $654,453 - $1.06 Million	71,525 Added 78.16%	163,035 $2.05 Million
Q3 2018 Nov 09, 2018	BUY	$9.55 - $12.64 $198,783 - $263,101	20,815 Added 29.44%	91,510 $0
Q2 2018 Aug 06, 2018	SELL	$5.39 - $9.66 $19,759 - $35,413	-3,666 Reduced 4.93%	70,695 $660,000
Q1 2018 May 15, 2018	BUY	$5.44 - $6.97 $22,886 - $29,322	4,207 Added 6.0%	74,361 $413,000
Q4 2017 Feb 09, 2018	BUY	$6.05 - $9.37 $424,431 - $657,342	70,154	70,154 $459,000

Others Institutions Holding VCYT

# of Institutions

316

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

Black Rock Inc. New York, NY

7.79M
Shares

$351 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.75M
Shares

$349 Million
0.0% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

5.02M
Shares

$226 Million
0.27% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

4.92M
Shares

$222 Million
1.59% of portfolio
Wellington Management Group LLP Boston, MA

4.23M
Shares

$191 Million
0.03% of portfolio

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account